Advita Announces FDA Clearance of Truliant^® Porous 3D Tibial Implant for Knee Replacement Surgery

GAINESVILLE, Fla. (Oct. 31, 2024) – Advita, a global medical technology leader, announced today it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for the Truliant^® Porous Tibial Tray, a 3D tibial knee implant.

The Truliant Porous Tibial Tray leverages additive manufacturing technology to create a porous structure designed to mimic the structure of cancellous bone. This design aims to facilitate both initial and biological fixation, designed to accommodate patients’ active lifestyles.

“With a focus on cementless fixation and increased efficiency, it is no surprise that Truliant Porous is the fastest growing segment of Advita’s knee portfolio,” said Advita Chief Marketing Officer and Senior Vice President of Large Joints Adam Hayden. “By expanding our porous offerings with the laser-printed tray, knee surgeons will have access to additional sizing and fixation options for the personalization of their patients’ total knee replacement procedures, improving upon Advita’s already successful cementless knee.”

Advita’s Truliant Porous laser-printed 3D tibial tray features peripherally placed tibial pegs, a dual v-channeled keel and optional cancellous bone screws designed to increase initial rotational stability and allow an increased bone-implant interface.

This FDA clearance marks a significant milestone for Advita, positioning the company to continue to address the growing demand for cementless knee solutions.

About Advita

Advita is a global medical technology leader that empowers orthopedic surgeons with innovative implants, surgical instruments and the Active Intelligence^® (AI) ecosystem of smart technologies to give patients EXACTLY what they need to regain mobility. Visit advita.com for more information and connect with us on LinkedIn, Vumedi, YouTube, Instagram and X.